SYNDAX PHARMACEUTICALS INC (SNDX)

US87164F1057 - Common Stock

22.22  -0.96 (-4.14%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to SNDX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 35.7. This target is 60.67% above the current price.
SNDX was analyzed by 19 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about SNDX.
In the previous month the buy percentage consensus was at a similar level.
SNDX was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 22.2223.2335.7035.7047.25 - 4.55% 60.67% 60.67% 112.65%
Up and Down Grades
Date Firm Action Rating
2024-04-26 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-27 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-20 JP Morgan Maintains Overweight -> Overweight
2024-02-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-01-31 ScotiaBank Downgrade Sector Outperform -> Sector Perform
2024-01-02 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-22 Mizuho Initiate Buy
2023-12-22 HC Wainwright & Co. Maintains Buy -> Buy
2023-10-26 Stifel Maintains Buy -> Buy
2023-10-25 B of A Securities Initiate Buy
2023-10-17 JP Morgan Maintains Overweight -> Overweight
2023-10-11 Goldman Sachs Initiate Buy
2023-10-02 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-16 JP Morgan Maintains Overweight -> Overweight
2023-08-04 HC Wainwright & Co. Reiterate Buy
2023-07-27 ScotiaBank Initiate Sector Outperform
2023-07-26 Barclays Maintains Overweight -> Overweight
2023-07-26 Citigroup Maintains Buy -> Buy
2023-07-25 Guggenheim Maintains Buy -> Buy
2023-07-25 B. Riley Securities Maintains Buy -> Buy
2023-07-24 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-11 Guggenheim Initiate Buy
2023-06-26 BTIG Maintains Buy
2023-05-10 Citigroup Maintains Buy
2023-05-09 HC Wainwright & Co. Maintains Buy
2023-03-07 JP Morgan Maintains Overweight
2023-03-02 Citigroup Maintains Buy
2023-03-01 Goldman Sachs Maintains Buy
2023-03-01 HC Wainwright & Co. Reiterate Buy